IMPACT OF PHARMACOVIGILANCE IN MONITORING ADVERSE DRUG REACTIONS: A RETROSPECTIVE STUDY
Main Article Content
Keywords
Adverse drug reactions, Pharmacovigilance, Causality assessment, Patient safety
Abstract
Adverse drug reactions (ADRs) are a major problem for healthcare systems around the world. Effective pharmacovigilance is therefore necessary to ensure patient safety. The purpose of this retrospective observational study, which ran from March to August 2023 in a tertiary care hospital for six months, was to evaluate the frequency, trends, and features of adverse drug reactions. There were 115 ADRs in all, with an average of 11 cases reported per month and an incidence of 0.95 cases per 1,000 patients. Skin/subcutaneous tissues (24.34%) and the gastrointestinal system (38.26%) were the most frequently affected organs, with adult patients aged 18-65 accounting for the majority of cases (64.34%). The most common mode of administration (72.17%) was oral. The severity assessment classified the ADRs as follows: 16.52% as severe, 36.53% as moderate, and 46.95% as mild. The causality analysis yielded 10.43% certain, 39.1% probable, and 30.43% plausible ADRs. Antihypertensives (25.2%), antimicrobials (39.13%), and antidiabetics (16.52%) were the most implicated drug classes. These results highlight the need for enhanced ADR reporting protocols and ongoing surveillance to improve patient safety, especially with regard to focused interventions for high-risk populations such as women and adults.
References
2. Kumar, B.N., Nayak, K., Singh, H., Dulhani, N., Singh, P., Tewari, P. “A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (jagdalpur), India.” Journal of young pharmacists: JYP 2010; vol. 2,1, 95-100. doi:10.4103/0975-1483.62222
3. Pathak, A.K., Kumar, M., Dokania, S., Mohan, L. and Dikshit, H. “A Retrospective Analysis of Reporting of Adverse Drug Reactions in a Tertiary Care Teaching Hospital: One Year Survey.” Journal of clinical and diagnostic research: JCDR, 2016; vol. 10(8). doi:10.7860/JCDR/2016/18826.8284
4. Iftikhar, S., Sarwar, M.R., Saqib, A. and Sarfraz, M. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan. PLoS One, 2018; 13(6), p.e0199456.
5. Gupta, A., Kaur, A., Shukla, P. and Chhabra, H. Adverse Drug Reactions pattern in a tertiary level teaching hospital: A Retrospective Study. Indian Journal of Pharmacy Practice, 2017; 10(1).
6. Jose, J. and Rao, P.G. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacological research, 2006; 54(3), pp.226-233.
7. Gor, A. P.; Desai, S. V.. Adverse Drug Reactions (ADR) in the inPatients of Medicine Department of a Rural Tertiary Care Teaching Hospital and Influence of Pharmacovigilance in Reporting ADR. Indian Journal of Pharmacology, 2008; 40(1):p 37-40, | DOI: 10.4103/0253-7613.40488
8. Arellano, A.L., Alcubilla, P., Farré, M. and Montané, E. Drug-related deaths in a tertiary hospital: Characteristics of spontaneously reported cases and comparison to cases detected from a retrospective study. Journal of clinical medicine, 2021; 10(18), p.4053.
9. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medicine unit meriting notification to the Committee on Safety of Medicines. Br J Cln Pharmacol. 1996; 42:423–9.
10. Watson, S., Caster, O., Rochon, P.A., Rujiter, H.D. “Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century.” EClinicalMedicine, 2019; vol. 17. doi:10.1016/j.eclinm.2019.10.001
11. Prajapati, K., Desai, M., Shah, S., Panchal, J., Kapadia, J., Dikshit, R. “An analysis of serious adverse drug reactions at a tertiary care teaching hospital.” Perspectives in clinical research vol. 2016; 7(4) 181-186. doi:10.4103/2229-3485.192044
12. Kourorian, Z., Fattahi, F., Pourpak, Z., Rasoolinejaf, M., Gholami, K. Adverse drug reactions in an Iranian department of adult infectious diseases. Eastern Mediterranean health journal, 2009; 15. 1351-7.
13. Petrova, G., Stoimenova, A., Georgiev, O., Dimitrova, M., Kamusheva, M., Petrova, D. “Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy.” SAGE open medicine, 2017; vol. 5.
14. Bajracharya, S. R., Ghimire, R., Gyanwali, P. and Khadka, A. “Causality Assessment of Adverse Drug Reaction Using Naranjo Probability Scale: A Retrospective Study”, Medical Journal of Shree Birendra Hospital, 2020; 19(1), pp. 16–19. doi: 10.3126/mjsbh.v19i1.21573.
15. Hacker, M. Adverse drug reactions. In Pharmacology, 2009; pp. 327-352. Academic Press.
16. Winterstein, A.G., Hatton, R.C., Gonzalez-Rothi, R., Johns, T.E. and Segal, R. Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports. American journal of health-system pharmacy, 2002; 59(18), pp.1742-1749.
17. Bailey, C., Peddie, D., Wickham, M.E., Badke, K., Small, S.S., Doyle‐Waters, M.M., Balka, E. and Hohl, C.M. Adverse drug event reporting systems: a systematic review. British journal of clinical pharmacology, 2016; 82(1), pp.17-29.
18. Palaian, S. Pharmacovigilance practices and activities: Issues, challenges, and future direction. In Social and Administrative Aspects of Pharmacy in Low-and Middle-Income Countries, 2018; pp. 145-162. Academic Press.
19. Kumar, V. Challenges and future consideration for pharmacovigilance. J Pharmacovigilance, 2013; 1(1), pp.1-3.
20. Rohilla, A., Singh, N., Kumar, V., Sharma, M.K., Dahiya, A. and Kushnoor, A. Pharmacovigilance: needs and objectives. Journal of Advanced Pharmacy Education and Research, 2012; 2(4-2012), pp.201-205.
21. Jose, J., Al Rubaie, M.H., Al Ramimmy, H. and Varughese, S.S. Pharmacovigilance: Basic concepts and an overview of the system in Oman. Sultan Qaboos University Medical Journal, 2021; 21(2), p.e161.
22. Khan, L.M., Al-Harthi, S.E., Saadah, O.I., Al-Amoudi, A.B., Sulaiman, M.I. and Ibrahim, I.M. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital. Saudi Med J, 2012; 33(8), pp.863-8.
23. Obebi Cliff-Eribo, K., Sammons, H., Star, K., Ralph Edwards, I., Osakwe, A. and Choonara, I. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Pediatrics and International Child Health, 2016; 36(4), pp.300-304.
24. Zheng, L., Jin, H.B., Guan, Y.Y. and Yang, J. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients. BMC Pharmacology and Toxicology, 2022; 23(1), p.62.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Ali Hassan
Gomal Centre of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Pakistan
Azra Batool
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Islamabad Campus, Pakistan
Ahmed Sadiq Sheikh
Faculty of Pharmacy, My University, Islamabad
Hashmat Ullah
Gomal Centre of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Pakistan;
Muhammad Masoom Akhtar
Department of Pharmacology, Faculty of Pharmacy, Hamdard University, Islamabad Campus, Pakistan
Aziz Ur Rahman
Department of Pharmacy, University of Malakand, Pakistan
Tehmina Rabbani
Department of Pharmaceutics, Balochistan University, Quetta, Pakistan
Mobina Manzoor
Lahore College for Women University
Sidra Mumtaz
Gomal Centre of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Pakistan
Pervaiz Akhtar Shah
Punjab University College of Pharmacy, University of the Punjab, Lahore, Pakistan, Allama Iqbal Campus, Lahore
Tariq Javed
Margalla College of Pharmacy, Margalla Institute of Health Sciences, Rawalpindi 46000 Pakistan
Sheikh Abdur Rashid
Gomal Centre of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, 29050, Pakistan